Motor and non-motor symptoms differences between Vascular Parkinsonism (VP) and Parkinson’s Disease (PD) patients in early stages
Objective: Compare motor and non-motor symptoms between VP and PD patients. Background: VP is usually described as “lower-body parkinsonism”, with early gait difficulties and postural…Self-report of cognitive functional abilities is inaccurate in PD-MCI and PDD
Objective: Evaluate concordance between self-reported and performance-based measures of cognitive functional abilities in PD by cognitive class. Background: PD-specific cognitive functional questionnaires, the Penn Daily…Non-Motor Symptoms in Patients with Parkinson’s Disease: Effect of Gender, Disease Severity, and Disease Phenotype
Objective: This study assessed the frequency of NMS in PD and their relationship with gender, severity and PD motor phenotypes. Background: Non-motor symptoms (NMS) is…Gender differences in Motor symptoms, Non-Motor symptoms and Quality of Life in Parkinson’s disease: COPPADIS-2015 study cohort
Objective: To assess gender differences among PD patients and health controls (HC) of the COPPADIS-2015 study cohort. Background: Men and women are different in genetic,…Adrenergic Receptor Modulation of Non-Motor Symptoms in Parkinson’s Disease
Objective: To analyze the correlation between the use of beta-blockers (BB) and the prevalence of non-motor symptoms in patients with Parkinson’s disease (PD). Background: In…Is Dizziness a sign before DLB onset?
Objective: I noticed that outpatients often continually complain about symptoms not found in PDD in DLB patients. In this time, I traced back the clinical…Nonmotor Symptoms in Parkinson’s Disease: 36-month Follow-up Study Comparing Bilateral Subthalamic Stimulation and Standard-of-care Medication
Objective: To examine 36-month effects of bilateral subthalamic nucleus (STN) deep brain stimulation (DBS) on nonmotor symptoms (NMS) and self-reported quality of life compared to…“Familial imprint” of Parkinson disease: the siblings’ cohort of PROPAG-AGEING
Objective: To verify if non-affected siblings (Sibs) of PD patients share candidate PD biomarkers in comparison with de-novo PD patients (PD) and healthy controls (HC).…Data quality, acceptability and reliability of the Movement Disorders Society – Non Motor Rating Scale (MDS-NMS)
Objective: To analyze the acceptability and reliability of the Movement Disorders Society – Non Motor Rating Scale (MDS-NMS). Background: Parkinson’s disease (PD) is a chronic…Quantitative Susceptibility Mapping: an Biomarker for Diagnosis of Parkinson’s Disease and Evaluation Patients’ Condition
Objective: To study deep gray matter susceptibility in Parkinson's Disease (PD) by using quantitative susceptibility mapping (QSM) and to assess the relationship between susceptibility value…
- « Previous Page
- 1
- …
- 39
- 40
- 41
- 42
- 43
- …
- 63
- Next Page »